FDA Nominee Overton Faces Senate Questioning
FDA Nominee Overton Faces Senate Questioning
The Spin
HandingOverton thehas FDAproven toshe's anothing loyalistmore whothan callsa abortionTrump corrosiveloyalist putsand ideologyhanding aheadher ofthe evidence,FDA andwould that'sbe a disaster for anyone who relies on safe medicine. A commissioner who already rejects the science on mifepristone can't be trusted to report honest findings or resist pressure to bury them. ContraceptionHer andresistance reproductiveto carepublicly shouldn'tcriticizing hingethe onpresident thecauses beliefsworries about how she would handle all of aher thinkFDA tank operativeresponsibilities.
Overton must be confirmed. America's lead in biotechnology is slipping toward Beijing while an outdated FDA bureaucracy slows the cures patients need right now. A physician who has already helped strip an outdated warning off hormone therapy and push honest guidance on chronic disease is exactly the kind of leader who treats people like adults. Delay here is a gift to competitors and a loss for families waiting on treatment.
The Controversies
Go Deeper
© 2026 Improve the News Foundation.
All rights reserved.
Version 7.4.1